跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-02
首页
药物
AT-02
AT-02
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CD5 specific T cell receptor cell or gene therapy
US 12479903 B2
申请人: MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT
优先权: 2019
EP
US
WO
5 件公开
COMPOSITIONS AND METHODS FOR IMPROVING REBAUDIOSIDE M SOLUBILITY
EP 3019198 A1
申请人: COCA COLA CO
优先权: 2013
CN
EP
WO
3 件公开
Vehicle comprising a distance control system
US 8077024 B2
申请人: LAUFER MARTIN
优先权: 2005
CN
US
3 件公开
Canine influenza virus and vaccine therefore
US 8246962 B2
申请人: CHO YOUNG SHIK
优先权: 2007
CN
US
3 件公开
Tetranectin-apolipoprotein A-I, lipid particles containing it and its use
US 9187550 B2
申请人: BADER MARTIN
优先权: 2010
CN
US
3 件公开
Compositions, methods and devices for forming implants from injected liquids
US 10123980 B2
申请人: PATHAK HOLDINGS LLC
优先权: 2017
US
3 件公开
ACYL-HYDRAZONE AND OXADIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF
US 2015191445 A1
申请人: UNIV FED DE SANTA CATARINA UFSC
优先权: 2011
CN
US
2 件公开
Pharmaceutical composition and food composition with strains of lactic acid bacteria for improving of kidney disease and inhibiting inflammation
US 10993973 B2
申请人: GLAC BIOTECH CO LTD
优先权: 2018
CN
US
2 件公开
Specific t cell receptors against epitopes of mutant MYD88L265P protein for adoptive T cell therapy
US 12365717 B2
申请人: CHARITE—UNIVERSITAETSMEDIZIN BERLIN
优先权: 2019
EP
US
2 件公开
Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel Lawsonia intracellularis serotype and hybridomas for producing the said antibodies
US 8557254 B2
申请人: BIERMANN YVONNE MARIA JOHANNA CORINA
优先权: 2009
US
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈